Everything, Everywhere, All At Once: A Comprehensive Breast Imaging Longitudinal Course


Disclosures

ARRS staff involved with this activity have nothing to disclose. Relevant financial disclosures for all planners and contributors have been mitigated. Below is a listing of activity's contributors and planners disclosures:

Planners

  • Courtney Moreno has nothing to disclose.
  • Tanya Moseley receives consulting fees from Hologic, Inc; Merit Medical, Inc, and Siemens, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Samantha Schulz has nothing to disclose.

Mammography

  • Tanya Moseley receives consulting fees from Hologic, Inc; Merit Medical, Inc, and Siemens, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Lonie Salkowski has nothing to disclose.
  • Stamatia Destounis received a research grant for her institution from Hologic, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Christopher Comstock receives honoraria from Hologic, Inc as a member of the advisory board; Bayer, Inc as a consultant, and GE Medical as a member of the speaker's bureau. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.

Breast MRI

  • Tanya Moseley receives consulting fees from Hologic, Inc; Merit Medical, Inc, and Siemens, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Susan Weinstein has nothing to disclose.
  • Samantha Heller has nothing to disclose.
  • Laura Heacock has nothing to disclose.
  • Basak Dogan has nothing to disclose.

Breast Ultrasound

  • Tanya Moseley receives consulting fees from Hologic, Inc; Merit Medical, Inc, and Siemens, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Gary Whitman is a consultant for Siemens. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Jean Seely has nothing to disclose.
  • Richard Barr has research grants from Phillips Ultrasound, Siemens Ultrasound, Hologic, Samsung Ultrasound, Cannon Medical and Mindray. Dr. Barr is a member of the speaker's bureau for Phillips Ultrasound, Siemens Ultrasound, Hologic, Cannon Medical, Bracco Diagnostics, and Mindray. He also serves on the Advisory Panel for Lantheus. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Luz Venta has nothing to disclose.

Challenging Biopsies and Localizations

  • Tanya Moseley receives consulting fees from Hologic, Inc; Merit Medical, Inc, and Siemens, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Robert Lynch has nothing to disclose.
  • Derek Nguyen receives consulting fees from Hologic, Inc.
  • Christine Edmonds has nothing to disclose.
  • Mary Guirguis has nothing to disclose.

Managing Difficult Cases

  • Tanya Moseley receives consulting fees from Hologic, Inc; Merit Medical, Inc, and Siemens, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Davis Teichgraeber has nothing to disclose.
  • Asha Bhatt has nothing to disclose.
  • Uzma Waheed has nothing to disclose.
  • Samantha Zuckerman has nothing to disclose.

Multimodality Imaging of Molecular Subtypes of Breast Cancer

  • Tanya Moseley receives consulting fees from Hologic, Inc; Merit Medical, Inc, and Siemens, Inc. The relevant financial disclosures listed here were mitigated using ARRS's mitigation policy for accredited activities.
  • Vilert Loving has nothing to disclose.
  • Beatriz Adrada has nothing to disclose.
  • Jocelyn Rapelyea has nothing to disclose
  • Haydee Ojeda-Fournier receives consulting fees from ViewPoint Medical and owns stock options in Curemetrix.